Thyrogen-IND (Thyrotropin Alfa Vials) 0.9mg x 1.0ml

Thyrotropin Alfa (Thyrogen-IND) is a synthetic thyroid-stimulating hormone used in thyroid cancer monitoring. This 0.9mg x 1.0ml vial form supports diagnostic procedures. Store between 2-8°C to maintain potency. Ideal for patients requiring thyroid cancer follow-up.

Strength

0.9mg x 1.0ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Genzyme Ireland ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Thyrotropin Alfa is used to stimulate thyroid tissue in patients undergoing thyroid cancer monitoring or ablation therapy. It helps detect residual or recurrent thyroid cancer by increasing thyroglobulin levels. This medication is also used before radioactive iodine treatment to enhance efficacy. Patients with differentiated thyroid cancer often rely on it for diagnostic clarity.

Side Effects

Thyrotropin Alfa may cause mild to moderate side effects such as nausea, headache, or fatigue. Some patients report flushing or dizziness shortly after administration. These effects are generally temporary and resolve within a few hours. Rarely, more pronounced reactions like muscle weakness or swelling may occur.

Precautions & Warnings

Thyrotropin Alfa should be handled with care and stored refrigerated between 2-8°C. Avoid freezing or exposure to high temperatures. Patients with known allergies to thyrotropin alfa or its components should not use this medication. Always consult a healthcare provider before starting treatment.

Avoid Interactions

Thyrotropin Alfa may interact with thyroid hormone medications, potentially reducing their effectiveness. Concurrent use of corticosteroids or other immunosuppressive drugs could alter its effects. Alcohol consumption should be avoided during treatment. Patients should disclose all medications to their healthcare provider.

References

Frequently Asked Questions

Thyrotropin Alfa is used to stimulate thyroid tissue in patients with thyroid cancer for monitoring or treatment preparation.

Store Thyrotropin Alfa vials refrigerated between 2-8°C and avoid freezing.

Consult a healthcare provider before combining Thyrotropin Alfa with other drugs, especially thyroid hormones or corticosteroids.

Common side effects include nausea, headache, fatigue, flushing, or dizziness.

Pregnant patients should consult their doctor before using Thyrotropin Alfa to assess potential risks.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.